Neucore Bio
PrivateLast Round
Grant
Sep 2, 2025
Total Funding Raised
$4.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Neucore Bio is a biotechnology company developing a pipeline of first-in-class antibody-based therapeutics to treat neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neucore Bio Comparables
Compare Neucore Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| STRM.BIO | 83% | |
| Carmine Therapeutics | 81% | |
| Vesigen Therapeutics | 81% | |
Neucore Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 2, 2025 | ||||
| Grant | Aug 6, 2025 | ||||
| Seed | Feb 6, 2024 | ||||
| Grant | Jul 11, 2023 |
Key People
Founding team and executive leadership
Neucore Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ohio State University | Seed |
| Ohio Third Frontier | Grant |
| National Center for Advancing Translational Sciences | Grant |
| National Institutes of Health (NIH) | Grant |
| CincyTech | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors grew 210% MoM, from 287 to 889.
- Jan 6, 2026
Monthly visitors grew 71% MoM.
Neucore Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neucore Bio's valuation, stock price, and market status.